Cardiac resynchronisation therapy for the treatment of heart failure: NICE technology appraisal guidance

AUTOR(ES)

Barnett, David

FONTE

BMJ Group

RESUMO

This NICE technology appraisal guidance on cardiac resynchronisation therapy provides additional treatment options for some of the groups of people covered in the earlier guidance on implantable cardioverter defibrillators.

Documentos Relacionados

• Alteplase for the treatment of acute ischaemic stroke: NICE technology appraisal guidance
• Cardiac resynchronisation works for eligible patients with heart failure
• What happened to evidence in NICE guidance on heart failure?
• Mortality in congestive heart failure: effects of vasodilator therapy.
• New guidelines for cardiac resynchronisation therapy: simplicity or complexity for the doctor?